CD4 and neoplasm: Our study suggests that CD11bloCD172lo cDC2 in tumors might play important roles for activation of CD4+ and CD8+ cytotoxic T cells, and reduction of those cDCs might be reflected by tumor progression in Dnase1l3-deficient mice.